Sugi Predict

Sugi Predict / Compounds / SCHEMBL21664221

SCHEMBL21664221

SCHEMBL21664221

CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSC(=N2)c2cc(cs2)CC(C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 4/20 0.55
▸ ITGB3 P05106 2/20 0.54
▸ ITGAV P06756 2/20 0.54
▸ ITGB5 P18084 2/20 0.54
▸ ITGB1 P05556 1/20 0.54
▸ ITGA5 P08648 1/20 0.54
▸ PLAU P00749 3/20 0.51
▸ KLKB1 P03952 6/20 0.50
▸ KEAP1 Q14145 2/20 0.46
▸ TCF4 P15884 1/20 0.46
▸ CTNNB1 P35222 1/20 0.46
▸ NNMT P40261 1/20 0.46
▸ NFE2L2 Q16236 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21663884 0.86 PLAU (0.52) ELANEPLAUKLKB1KEAP1NNMT
SCHEMBL24380214 0.84 PLAU (0.50) ELANEPLAUKLKB1KEAP1NNMT
SCHEMBL21663885 0.83 PLAU (0.49) ELANEPLAUKLKB1KEAP1NNMT
SCHEMBL24380221 0.83 PLAU (0.44) ELANEITGB3ITGAVITGB5ITGB1
SCHEMBL21664075 0.80 NNMT (0.56) ELANEITGB3ITGAVITGB5ITGB1
SCHEMBL23104993 0.74 PLAU (0.68) ELANEITGB3ITGAVITGB5ITGB1
SCHEMBL22256705 0.74 PLAU (0.68) ITGB3ITGAVITGB5ITGB1ITGA5
SCHEMBL24380222 0.74 PLAU (0.48) ELANEITGB3ITGAVITGB5ITGB1
SCHEMBL21664220 0.74 PLAU (0.48) ELANEITGB3ITGAVITGB5ITGB1
SCHEMBL22341394 0.73 ITGB3 (0.70) ELANEITGB3ITGAVITGB5ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11319347-B2 Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound FUJIFILM CORPORATION (JP) 2022-05-03 — — US disclosed
US-20200040039-A1 PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND FUJIFILM CORPORATION (JP) 2020-02-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200040039-A1 PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND VIP, NPPA, NGLY1 ELANE 1865/4885ITGB3 4776/4885ITGAV 3699/4885
US-11319347-B2 Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound VIP, NPPA, NGLY1 ELANE 1865/4885ITGB3 4776/4885ITGAV 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.